AP1485A - Orally administered controlled delivery system for once daily administration of ciprofloxacin. - Google Patents

Orally administered controlled delivery system for once daily administration of ciprofloxacin.

Info

Publication number: AP1485A
Authority: AP; ARIPO
Prior art keywords: ciprofloxacin; once daily; delivery system; orally administered; daily administration
Prior art date: 2000-03-03

Application number

APAP/P/2002/002627A

Other languages

English (en)

Other versions

AP2002002627A0 (en

Inventor

Naresh Talwar

John N Staniforth

Ashok Rampal

Gour Mukherji

Narayanan Badri N Vishwanathan

Brij Khera

Original Assignee

Ranbaxy Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-03

Filing date

2001-02-28

Publication date

2005-10-31

2001-02-28 Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd

2002-09-30 Publication of AP2002002627A0 publication Critical patent/AP2002002627A0/xx

2005-10-31 Application granted granted Critical

2005-10-31 Publication of AP1485A publication Critical patent/AP1485A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

APAP/P/2002/002627A 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin. AP1485A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US51788700A	2000-03-03	2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (2)

Publication Number	Publication Date
AP2002002627A0 AP2002002627A0 (en)	2002-09-30
AP1485A true AP1485A (en)	2005-10-31

Family

ID=24061635

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
APAP/P/2001/002084A AP2001002084A0 (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily adminstration of ciprofloxacin
APAP/P/2002/002627A AP1485A (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily administration of ciprofloxacin.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/2001/002084A AP2001002084A0 (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily adminstration of ciprofloxacin

Country Status (31)

Country	Link
EP (1)	EP1263409A1 (xx)
JP (1)	JP2003525229A (xx)
KR (1)	KR20030009374A (xx)
CN (1)	CN1420763A (xx)
AP (2)	AP2001002084A0 (xx)
AR (1)	AR032614A1 (xx)
AU (1)	AU3589701A (xx)
BG (1)	BG107055A (xx)
BR (1)	BR0108958A (xx)
CA (1)	CA2400950A1 (xx)
CZ (1)	CZ20022883A3 (xx)
DO (1)	DOP2001000130A (xx)
EA (1)	EA200200914A1 (xx)
EC (1)	ECSP013952A (xx)
EE (1)	EE200200497A (xx)
GT (1)	GT200100033A (xx)
HN (1)	HN2001000038A (xx)
HR (1)	HRP20020715A2 (xx)
HU (1)	HUP0204417A3 (xx)
IL (1)	IL151553A0 (xx)
IS (1)	IS6532A (xx)
MX (1)	MXPA02008568A (xx)
NO (1)	NO20024108L (xx)
NZ (1)	NZ520927A (xx)
OA (1)	OA12381A (xx)
PE (1)	PE20011113A1 (xx)
PL (1)	PL365071A1 (xx)
SK (1)	SK12542002A3 (xx)
WO (1)	WO2001064183A1 (xx)
YU (1)	YU66202A (xx)
ZA (1)	ZA200206764B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0209265D0 (en)	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
US20030229101A1 (en) *	2002-06-06	2003-12-11	Sherman Bernard Charles	Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de)	2003-11-04	2005-06-09	Bayer Healthcare Ag	Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1745775B1 (en) *	2005-07-19	2008-05-28	Ethypharm	Gastroretentive formulations and manufacturing process thereof.
DE602006012962D1 (de) *	2006-07-19	2010-04-29	Tabuk Pharmaceutical Mfg Co	Pharmazeutische Zubereitungen von Ciprofloxacin
EP3247384B1 (en)	2015-01-14	2023-10-04	The Regents of the University of Colorado, a body corporate	In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
CA3015400C (en) *	2016-02-23	2024-10-29	Matripharm International Inc.	DUAL-RATE, HIGH-DRUGGED COMPOSITION
AU2017236977B2 (en)	2016-03-24	2022-05-26	Immunomolecular Therapeutics, Inc.	Methods of treating autoimmune disease
US11052060B2 (en)	2018-02-12	2021-07-06	The Regents Of The University Of Colorado, A Body Corporate	Compounds and methods for treating autoimmunity
US11013707B2 (en)	2018-03-23	2021-05-25	The Regents Of The University Of Colorado, A Body Corporate	Administration of oral methyldopa
CN109806237A (zh) *	2019-03-13	2019-05-28	悦康药业集团上海制药有限公司	一种乳酸环丙沙星泡腾片及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5292518A (en) *	1988-06-28	1994-03-08	Hauser-Kuhrts	Prolonged-release drug tablet formulations
EP0669129A2 (de) *	1994-02-28	1995-08-30	Bayer Ag	Expandierbare Arzneiformen mit kontrollierter Wirkstoffabgabe
WO2000012198A1 (de) *	1998-08-28	2000-03-09	Koch, Berthold	Spülluft-regler für eine trockenvorrichtung für druckluft

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0624959A (ja) *	1991-10-04	1994-02-01	Bayer Yakuhin Kk	胃内浮遊型薬物徐放性固形製剤
EA004443B1 (ru) *	1998-09-14	2004-04-29	Рэнбакси Лабораториз Лимитед	Лекарственная форма для контролируемого высвобождения ципрофлоксацина для приема один раз в день

2001
- 2001-02-28 PL PL01365071A patent/PL365071A1/xx not_active Application Discontinuation
- 2001-02-28 NZ NZ520927A patent/NZ520927A/xx unknown
- 2001-02-28 EP EP01908038A patent/EP1263409A1/en not_active Withdrawn
- 2001-02-28 AP APAP/P/2001/002084A patent/AP2001002084A0/en unknown
- 2001-02-28 CZ CZ20022883A patent/CZ20022883A3/cs unknown
- 2001-02-28 CA CA002400950A patent/CA2400950A1/en not_active Abandoned
- 2001-02-28 CN CN01805998A patent/CN1420763A/zh active Pending
- 2001-02-28 OA OA1200200267A patent/OA12381A/en unknown
- 2001-02-28 EA EA200200914A patent/EA200200914A1/ru unknown
- 2001-02-28 BR BR0108958-7A patent/BR0108958A/pt not_active IP Right Cessation
- 2001-02-28 AR ARP010100957A patent/AR032614A1/es not_active Application Discontinuation
- 2001-02-28 YU YU66202A patent/YU66202A/sh unknown
- 2001-02-28 IL IL15155301A patent/IL151553A0/xx unknown
- 2001-02-28 EE EEP200200497A patent/EE200200497A/xx unknown
- 2001-02-28 HR HRP20020715 patent/HRP20020715A2/hr not_active Application Discontinuation
- 2001-02-28 KR KR1020027011441A patent/KR20030009374A/ko not_active Ceased
- 2001-02-28 HU HU0204417A patent/HUP0204417A3/hu unknown
- 2001-02-28 AP APAP/P/2002/002627A patent/AP1485A/en active
- 2001-02-28 AU AU35897/01A patent/AU3589701A/en not_active Abandoned
- 2001-02-28 WO PCT/IB2001/000279 patent/WO2001064183A1/en not_active Ceased
- 2001-02-28 JP JP2001563081A patent/JP2003525229A/ja not_active Withdrawn
- 2001-02-28 SK SK1254-2002A patent/SK12542002A3/sk unknown
- 2001-02-28 MX MXPA02008568A patent/MXPA02008568A/es unknown
- 2001-03-01 EC EC2001003952A patent/ECSP013952A/es unknown
- 2001-03-01 PE PE2001000206A patent/PE20011113A1/es not_active Application Discontinuation
- 2001-03-01 GT GT200100033A patent/GT200100033A/es unknown
- 2001-03-02 DO DO2001000130A patent/DOP2001000130A/es unknown
- 2001-03-02 HN HN2001000038A patent/HN2001000038A/es unknown
2002
- 2002-08-23 ZA ZA200206764A patent/ZA200206764B/en unknown
- 2002-08-28 NO NO20024108A patent/NO20024108L/no unknown
- 2002-08-28 IS IS6532A patent/IS6532A/is unknown
- 2002-09-02 BG BG107055A patent/BG107055A/bg unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5292518A (en) *	1988-06-28	1994-03-08	Hauser-Kuhrts	Prolonged-release drug tablet formulations
EP0669129A2 (de) *	1994-02-28	1995-08-30	Bayer Ag	Expandierbare Arzneiformen mit kontrollierter Wirkstoffabgabe
WO2000012198A1 (de) *	1998-08-28	2000-03-09	Koch, Berthold	Spülluft-regler für eine trockenvorrichtung für druckluft

Also Published As

Publication number	Publication date
ECSP013952A (es)	2002-04-23
GT200100033A (es)	2001-10-25
HUP0204417A2 (en)	2003-05-28
EA200200914A1 (ru)	2003-02-27
DOP2001000130A (es)	2004-03-31
HN2001000038A (es)	2005-03-23
BR0108958A (pt)	2003-09-30
PL365071A1 (en)	2004-12-27
CZ20022883A3 (cs)	2003-04-16
EE200200497A (et)	2004-02-16
BG107055A (bg)	2003-06-30
AU3589701A (en)	2001-09-12
EP1263409A1 (en)	2002-12-11
CN1420763A (zh)	2003-05-28
AP2001002084A0 (en)	2001-03-31
AR032614A1 (es)	2003-11-19
MXPA02008568A (es)	2003-02-24
JP2003525229A (ja)	2003-08-26
IL151553A0 (en)	2003-04-10
AP2002002627A0 (en)	2002-09-30
PE20011113A1 (es)	2001-10-14
CA2400950A1 (en)	2001-09-07
YU66202A (sh)	2005-09-19
SK12542002A3 (sk)	2003-05-02
NO20024108L (no)	2002-10-25
KR20030009374A (ko)	2003-01-29
ZA200206764B (en)	2003-03-04
WO2001064183A1 (en)	2001-09-07
NZ520927A (en)	2003-06-30
IS6532A (is)	2002-08-28
HRP20020715A2 (en)	2004-12-31
OA12381A (en)	2004-09-06
NO20024108D0 (no)	2002-08-28
HUP0204417A3 (en)	2005-03-29

Publication	Publication Date	Title
BG105857A (en)	2002-04-30	Pregelatinized starch in a controlled release formulation
MY118371A (en)	2004-10-30	Tetrahydrolipstatin containing compositions
PL334656A1 (en)	2000-03-13	Dosage forms and methods of achieving betterement in cases of erection disorderamong male patients
IS4146A (is)	1994-10-31	Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
IL143375A0 (en)	2002-04-21	Sustained release matrix systems for highly soluble drugs
BG105339A (en)	2001-11-30	Orally administered controlled drug delivery system providing temporal and spatial control
AU2001263228A1 (en)	2001-11-26	Rapidly disintegrating solid oral dosage form
MXPA04003807A (es)	2004-07-30	Formulaciones farmaceuticas de 5, 7, 14-trianzatetraciclo [10.3.1.02, 11, 04, 9]-hexadeca -2 (11), 3, 5, 7, 9-pentaeno.
IL150895A0 (en)	2003-02-12	Oral, nasal and pulmonary formulations of copolymer-1
EP0966966A3 (en)	2000-02-09	Nefazodone dosage form
NO306894B1 (no)	2000-01-10	Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet
AP1485A (en)	2005-10-31	Orally administered controlled delivery system for once daily administration of ciprofloxacin.
AP2003002763A0 (en)	2003-03-31	Controlled release formulations for oral administration
MY129314A (en)	2007-03-30	Pharmaceutical composition comprising sumatriptan
MY137516A (en)	2009-02-27	Pharmaceutical composition comprising lumiracoxib
ES2130081B1 (es)	2000-01-01	Comprimido de maleato de trimebutina con recubrimiento laminar.
BR0013719A (pt)	2002-07-23	Dosagem oral de liberaçâo controlada, apropriada para administração oral
MXPA06000332A (es)	2006-03-30	Nueva composicion farmaceutica solida que comprende amisulprida.
HRP20020258B1 (hr)	2007-05-31	Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
GEP20043377B (en)	2004-04-13	Pharmaceutical Complex
AU2503900A (en)	2000-08-01	Sulfated phosphatidylinositols, their preparation and use
UY26605A1 (es)	2001-10-25	Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina
ECSP982396A (es)	1999-01-12	Composiciones que contienen tetrahidrolipstatina
AU2001295839A1 (en)	2002-05-15	Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa
MY145885A (en)	2012-05-15	Controlled release formulations for oral administration